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Aims Limited information is available regarding the relationship between coronary vessel dominance and prognosis. There-
fore, the purpose of this study was to determine the prognostic value of coronary vessel dominance in relation to
significant coronary artery disease (CAD) in patients referred for computed tomography coronary angiography
(CTA).
Methods
and results
The study population consisted of 1425 patients (869 men, 57+12 years) referred for CTA. To evaluate the impact
of vessel dominance and significant CAD on CTA on outcome, patients were followed during a median period of 24
months for the occurrence of non-fatal myocardial infarction and all-cause mortality. The presence of a left dominant
system was identified as a significant predictor for non-fatal myocardial infarction and all-cause mortality (HR: 3.20;
95% CI: 1.67–6.13, P, 0.001) and had incremental value over baseline risk factors and severity of CAD on CTA. In
addition, in the subgroup of patients with significant CAD on CTA, patients with a left dominant system had a worse
outcome compared with patients with a right dominant system (cumulative event rates: 9.5% and 35% at 3-year
follow-up for a right and left dominant coronary artery system, respectively, log-rank P, 0.001).
Conclusions The presence of a left dominant system was identified as an independent predictor of non-fatal myocardial infarction
and all-cause mortality, especially in patients with significant CAD on CTA. Therefore, the assessment of coronary
vessel dominance on CTA may further enhance risk stratification beyond the assessment of significant CAD on CTA.
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Introduction
Non-invasive computed tomography coronary angiography (CTA)
is increasingly used in clinical practice for visualization of the cor-
onary arteries in patients with suspected or known coronary
artery disease (CAD).1–3 Multiple studies demonstrated high
diagnostic accuracy of CTA in detection of CAD. In addition to
the good diagnostic performance, CTA also provides important
prognostic information.4,5 Several studies have shown that patients
with significant CAD detected on CTA have worse overall
outcome compared with patients without significant CAD.6,7
However, CTA not only provides information about the presence
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and degree of coronary stenosis, it also allows the evaluation of
cardiac anatomy including coronary vessel dominance. As a
result, coronary vessel dominance is routinely determined on
CTA. In the general population, a right dominant coronary artery
system is most prevalent, 87–89%, while a left dominant coron-
ary artery system has a prevalence of 7–8% and a balanced coron-
ary artery system is present in 4% of the population.8–10
Although coronary vesssel dominance is easily assessed on CTA,
limited information is available considering the prognostic value
of coronary vessel dominance in patients referred for CTA. More-
over, the relationship between coronary vessel dominance and the
prognostic importance of a significant stenosis remains unclear.
Therefore, the purpose of this study was to evaluate the prognos-
tic relevance of coronary vessel dominance in the presence and
absence of CAD determined on CTA.
Methods
Patients and study protocol
The study population consisted of consecutive patients who were clin-
ically referred for CTA because of typical chest pain or atypical chest
pain in combination with an elevated risk profile for cardiovascular
disease. Patients were enrolled at the Leiden University Medical
Center in the Netherlands and at the University Hospital Zurich in
Switzerland. Exclusion criteria were: (i) previous coronary artery
bypass graft surgery (CABG); (ii) (supra)ventricular arrhythmias; (iii)
renal insufficiency (defined as a glomerular filtration rate ,30 mL/
min); (iv) known allergy to iodinated contrast agent; (v) severe claus-
trophobia; and (vi) pregnancy. Patient data were entered consecutively
into the departmental patient information systems and retrospectively
analysed. Patients with uninterpretable CTA examination were
excluded from the analysis. Patients referred for revascularization
after CTA remained in the study population.
Computed tomography coronary
angiography data acquisition
Patients were scanned using a 64-row CT scanner (Aquillion64,
Toshiba Medical Systems, Otawara, Japan; General Electrics LightSpeed
VCT, Milwaukee, WI, USA) or with a 320-row CT scanner (Aquilion
ONE, Toshiba Medical Systems). Before examination the patient’s
heart rate and blood pressure were monitored. In the absence of con-
traindications, patients with a heart rate exceeding 65 b.p.m. received
50 or 100 mg oral metoprolol, or 5–10 mg metoprolol, intravenously.
Scan acquisition parameters have been previously described.5,11,12 A
reconstruction data set with the least motion artefacts was evaluated,
typically acquired during a mid-diastolic phase.
Computed tomography coronary
angiography image analysis
Computed tomography coronary angiography reconstructions were
transferred to dedicated workstations (Vitrea2, Vital Images, USA
and Advantage, GE Healthcare, USA). Computed tomography coron-
ary angiography image analysis was performed by two observers in
consensus, experienced in the evaluation of CTA. Coronary anatomy
and coronary vessel dominance were assessed in a standardized
manner by dividing the coronary artery tree into 17 segments accord-
ing to the guidelines of the American Heart Association.13 A coronary
artery system was classified as right dominant when the posterior des-
cending artery (PDA) originated from the right coronary artery (RCA),
whereas a coronary artery system was considered left dominant if the
PDA originated from the left circumflex artery (LCX). A coronary
artery system was classified as balanced, when the PDA originated
from the RCA in combination with a large posterolateral branch origin-
ating from the LCX reaching near the posterior interventricular
groove. Subsequently, the presence of CAD was assessed by scrolling
through axial images, simultaneous with visual assessment of curved
multiplanar reconstructions in at least two orthogonal planes. All 17
coronary segments were scored as (i) normal CTA or minor wall ir-
regularities ,30%, (ii) non-obstructive CAD (defined as 30–50%
luminal narrowing), or (iii) significant CAD (defined as ≥50% luminal
narrowing), as previously described.5 In case of stented coronary seg-
ments, the presence of in-stent restenosis was analysed as described
before.14,15 Computed tomography coronary angiography results on
a per patient basis were scored according to the five-step score asses-
sing both degree of stenosis and number of vessels affected, as previ-
ously described by Chow et al.16 The five categories were normal
coronaries or minimal wall irregularities ,30%, non-obstructive
CAD, and one-, two-, and three-vessel disease.
Patient follow-up
Patients were entered prospectively into the departmental patient in-
formation system over a period of 3 years. Follow-up information was
obtained for all patients 6 months post-index CTA of the last patient
entering the study. Based on the difference in inclusion date, the
follow-up time varied among patients with a minimal follow-up time
of 6 months and a maximal follow-up time of 3.5 years. Patient follow-
up data were gathered by three observers blinded to the baseline CTA
results using clinical visits or standardized telephone interviews.
Outcome measures
The primary endpoint was the composite of non-fatal myocardial in-
farction (MI) and all-cause mortality. Non-fatal MI was defined based
on the criteria of typical chest pain, elevated cardiac enzyme levels,
and typical changes on the ECG.17 A secondary outcome was the oc-
currence of cardiac adverse events, defined as the composite of non-
fatal MI and cardiac death. To obtain the cause of death, the electronic
health records of the cardiology department were first consulted. If
the cause of death could not be retrieved from these health
records, general practitioners were contacted. Cases that remained
unidentified were classified as unknown.
Statistical analysis
Continuous variables were expressed as means and standard devia-
tions (SD) and categorical baseline data were expressed in numbers
and percentages. Kaplan–Meier analyses stratified for coronary
vessel dominance were performed to estimate the cumulative inci-
dences of the primary and secondary endpoints in the total population,
in patients without significant CAD on CTA and in patients with signifi-
cant CAD on CTA. Annual event rates were calculated by dividing the
Kaplan–Meier event rates by the mean number of years of follow-up.
Subsequently, Cox regression analysis for the primary and second-
ary endpoints was used to determine the prognostic value of coronary
vessel dominance and CAD on CTA. The number of covariables
included in the multivariate analysis was adjusted to the number of
events. According to univariate significance and baseline differences
between groups, age, smoking, and diabetes were included in the
multivariate model, together with the confounding factors of gender
and known CAD. The increase in global Chi-square values was used
to determine the incremental prognostic value of coronary vessel
dominance over CAD on CTA and clinical risk factors. To avoid the
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potential of overfitting in this extensive multivariate Cox regression
model, two additional models were created only correcting for age,
gender, and overall plaque burden (model 1) and for age, gender,
and proximally located CAD (model 3). Furthermore, the prognostic
value of significant stenosis location was determined for all patients,
patients with a right dominant coronary artery system and patients
with a left dominant coronary artery system. Adjusted hazard ratios
(HRs) with 95% confidence intervals (CIs) were reported. Statistical
analysis was performed using SPSS software (version 16.0, SPSS, Inc.,
Chicago, IL, USA). A P-value ,0.05, by a two-sided test, was consid-
ered statistically significant.
Results
Patient population
The study population consisted of 1467 consecutive patients clin-
ically referred for CTA at the Leiden University Medical Center
(n ¼ 999, 68%) and at the University Hospital Zurich (n ¼ 468,
32%). In the total population, the CTA examination was uninter-
pretable due to poor image quality in 42 (2.9%) patients. As a
result, a total of 1425 patients (57+ 12 years old, 58% men)
remained for the analysis. In total, 1256 patients (88%) had a
right dominant coronary artery system, while 131 patients (9.2%)
had a left dominant and 38 patients (2.7%) had a balanced coronary
artery system. The baseline characteristics of the patient popula-
tion, categorized by coronary vessel dominance, are presented in
Table 1. Overall baseline characteristics were similar between
groups, although significant differences were observed for the
presence of diabetes (22, 34, and 45% for a right, left, and balanced
coronary artery system, respectively, P ¼ 0.003).
Follow-up was obtained for 1347 (94.5%) patients, while 78
(5.5%) patients were lost to follow-up. The distribution of coron-
ary vessel dominance was comparable between patients with and
without complete follow-up. Furthermore, patients lost to follow-
up were younger (53+11 years old), had less hypertension
(28.2%) and diabetes (9.0%), and were less often known with
CAD (3.8%) compared with patients with follow-up.
Computed tomography coronary
angiography results
Computed tomography coronary angiography was classified as
normal CTA or minor wall irregularities ,30% in 503 (35%)
patients, non-significant CAD in 479 (34%) patients, and significant
CAD in 443 (31%) patients (Table 2). Of those patients with signifi-
cant CAD on CTA, 246 patients had one-vessel disease, 125
patients had two-vessel disease, and 72 patients were diagnosed
with three-vessel disease. Furthermore, the distribution of signifi-
cant CAD on CTA did not differ significantly among patients
with a right dominant, left dominant, and balanced coronary
artery systems. However, normal CTA or minor wall irregularities
,30% were observed less frequently in patients with a right dom-
inant coronary artery system compared with patients with a left
dominant and balanced coronary artery system (34, 44, and 45%,
respectively, P ¼ 0.031) (Table 2). In addition, there was no differ-
ence in the extent of CAD, since the number of vessels affected
and the overall plaque burden were comparable between groups
(Table 2). Specifically looking at significant stenosis location, the
prevalence of a significant stenosis in the RCA was higher in
patients with a right dominant coronary artery system when com-
pared with patients with a left dominant and balanced coronary
artery system (16, 7, and 8%, respectively, P ¼ 0.020), while the
prevalence of a stenosis in the LAD and LCX did not differ
among groups (Table 2).
Cardiac events
During a median follow-up time of 24 months (25–75th percentile:
15–37 months), the composite endpoint occurred in 57 (4.0%)
patients. Specifically, non-fatal MI was reported in 18 (1.3%)
patients, while cardiac death occurred in 9 (0.6%) patients and
30 (2.1%) patients died due to non-cardiac death. Causes of the
30 non-cardiac deaths were malignancy (6 deaths), sepsis
(5 deaths), respiratory insufficiency (4 deaths), vascular events
(3 deaths), postoperative non-cardiac complications (3 deaths),
and other causes (7 deaths). In two cases the reason of death
remained unknown. A total of 120 (8.4%) patients underwent
revascularization. In 87 (6.1%) revascularisation was performed by
percutaneous coronary intervention (PCI), and in 33 (2.3%) by
CABG. No differences in referral for coronary revascularization
after CTA were observed between the different coronary vessel
dominance groups (revascularization rate of 8.6, 7.6 and 5.3% in
patients with right dominant, left dominant, and balanced coronary
artery systems, respectively; P ¼ 0.706). Peri-procedural complica-
tions were observed in four (0.3%) patients. These four patients had
a right dominant coronary artery system and experienced a non-
fatal MI within 90 days after revascularization by PCI.
Event rates during follow-up in relation to
coronary artery disease and coronary
vessel dominance on computed
tomography coronary angiography
When comparing the differences in event-free survival in the total
study population according to coronary vessel dominance, the cu-
mulative incidence of non-fatal MI and all-cause mortality after
3 years of follow-up was 17% in patients with a left dominant cor-
onary artery system, compared with 4.8 and 2.7% in patients with
right dominant and balanced coronary artery systems, respectively
(log-rank P, 0.001; Figure 1). After stratification according to the
absence or presence of significant CAD on CTA, patients without
significant CAD were shown to have good prognosis with low
annual event rates for adverse cardiac events of 0.3%, as well as
low annual event rates for the composite of non-fatal MI and all-
cause mortality of 0.9% (Table 3). Furthermore, in patients
without significant CAD no significant difference was observed in
event-free survival between right dominant and left dominant cor-
onary artery systems, with cumulative event rates of 2.4 and 7.4%
after 3 years of follow-up for a right and left dominant coronary
artery system, respectively (log-rank P ¼ 0.106; Figure 2A).
However, in patients with significant CAD higher annual event
rates were observed for adverse cardiac events and the composite
of non-fatal MI and all-cause death of 2.2 and 3.8%, respectively
(Table 3). In addition, in the subgroup of patients with significant
CAD differences in prognosis were observed between patients
with a right dominant and left dominant coronary artery system,
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Table 1 Patient characteristics
Total,
n5 1425
Right dominant,
n5 1256
Left dominant,
n 5 131
Balanced,
n5 38
P-value
Gender (male) (%) 824 (58) 733 (58) 74 (57) 17 (45) 0.233
Age (years) 57+12 57+12 56+12 54+15 0.095
Reason for referral (%)
Typical chest pain 213 (15) 190 (15) 18 (14) 5 (13) 0.870
Atypical chest pain and elevated risk
profile
1212 (85) 1066 (85) 113 (86) 33 (87) 0.870
Clinical risk factors (%)
Diabetes 338 (24) 276 (22) 45 (34) 17 (45) 0.003
Hypercholesterolaemiaa 551 (39) 495 (39) 44 (34) 12 (32) 0.232
Hypertensionb 683 (48) 599 (48) 61 (47) 23 (61) 0.299
Family history of CADc 543 (38) 476 (38) 51 (39) 16 (42) 0.894
Current smoking 354 (25) 302 (24) 43 (33) 9 (24) 0.102
Obesity (BMI ≥ 30 kg/m2) 257 (18) 222 (19) 24 (18) 11 (29) 0.227
Known CAD (%)
Previous myocardial infarction 126 (8.8) 116 (9.2) 8 (6.1) 2 (5.3) 0.357
Previous PCI 155 (11) 140 (11.1) 10 (7.6) 5 (13.2) 0.423
BMI, body mass index; CAD, coronary artery disease; PCI, percutaneous coronary intervention.
Data are presented as mean values+ SD or n (%).
aSerum total cholesterol ≥230 mg/dL and/or serum triglycerides ≥200 mg/dL or treatment with lipid-lowering drugs.
bDefined as systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg and/or the use of antihypertensive medication.
cDefined as the presence of coronary artery disease in first-degree family members at ,55 years in men and ,65 years in women.
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Table 2 Computed tomography coronary angiography results
Total,
n 5 1425
Right dominant,
n5 1256
Left dominant,
n 5 131
Balanced,
n5 38
P-value
CAD on CTA (%)
Normal CTA or minor wall irregularities
(,30%)
503 (35) 428 (34) 58 (44) 17 (45) 0.031
Non-significant CAD on CTA (30–50%) 479 (34) 428 (34) 38 (29) 13 (34) 0.504
Significant CAD on CTA (.50%) 443 (31) 400 (32) 35 (27) 8 (21) 0.186
One vessel disease (.50%) 246 (17) 224 (18) 18 (14) 4 (11) 0.268
Two vessel disease (.50%) 125 (8.7) 110 (7.7) 13 (9.9) 2 (5.3) 0.670
Three vessel disease (.50%) 72 (5.1) 66 (5.3) 4 (3.1) 2 (5.3) 0.548
Significant stenosis location (%)
RCA 217 (15) 205 (16) 9 (7.2) 3 (8.0) 0.020
LM 27 (1.9) 25 (2.0) 1 (0.8) 1 (2.6) 0.325
LAD 324 (23) 290 (23) 27 (21) 7 (18) 0.723
LCX 163 (11) 140 (11) 19 (15) 4 (11) 0.484
Overall plaque burden
Mean number of diseased segments (.30%) 3.1+3.5 3.2+3.5 2.5+3.2 3.6+4.3 0.697
Mean number of proximal diseased segments
(.30%)
1.3+1.4 1.3+1.4 1.1+1.3 1.4+1.5 0.071
CAD, coronary artery disease; CTA, computed tomography coronary angiography; RCA, right coronary artery; LAD, left anterior descending artery; LCX, left circumflex artery;
LM, left main artery.
Comparison of CTA results between coronary vessel dominance groups. Data are presented as mean values+ SD or n (%).
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because patients with a left dominant coronary artery system
showed a significantly worse outcome with a cumulative incidence
of non-fatal MI and all-cause mortality of 35% compared with 9.5%
in patients with a right dominant coronary artery system within a
follow-up period of 3 years (log-rank P, 0.001; Figure 2B).
Incremental prognostic value
The incremental value of coronary vessel dominance and CAD on
CTA was assessed for non-fatal MI and all-cause mortality
(Table 4). A left dominant coronary artery system was identified
as a significant predictor of the primary endpoint and remained a
significant predictor after correction for baseline risk factors and
CAD on CTA, with a HR of 3.20 (95% CI: 1.67–6.13, P,
0.001). Balanced coronary artery system did not predict for
events (HR: 0.82; 95% CI: 0.11–6.05, P ¼ 0.842). In addition, sig-
nificant CAD in one vessel was also identified as a predictor for
non-fatal MI and all-cause mortality, with a HR of 2.79 (95% CI:
1.03–7.60, P ¼ 0.045). Subsequently, the risk was increased
when more vessels were diseased, with a HR of 3.59 (95% CI:
1.24–10.40, P ¼ 0.019) and a HR of 4.14 (95% CI: 1.31–13.06,
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Table 3 Adverse (cardiac) events in patients with right and left dominant coronary artery systems stratified for
significant CAD on CTA
n All
death
(%)
Cardiac
death (%)
Non-fatal
MI (%)
Combined
cardiac death,
non-fatal
MI (%)
Annual
event rate
(%)
Combined all
death, non-fatal
MI (%)
Annual
event rate
(%)
Total 1387 38a (2.7) 9 (0.7) 18 (1.2) 27 (1.9) 1.0 56 (4.0) 1.9
Right dominant 1256 27 (2.1) 4 (0.3) 14 (1.1) 18 (1.4) 0.8 41 (3.3) 1.6
Left dominant 131 11 (8.4) 5 (3.8) 4 (3.1) 9 (6.9) 2.8 15 (11.5) 4.5
Log-rank P-value ,0.001 0.061 0.047 ,0.001 ,0.001
No significant CAD 952 15 (1.6) 2 (0.2) 4 (0.4) 6 (0.6) 0.3 19 (2.0) 0.9
Right dominant 856 12 (1.4) 2 (0.2) 3 (0.4) 5 (0.6) 0.3 15 (1.8) 0.8
Left dominant 96 3 (3.1) 0 (0.0) 1 (1.0) 1 (1.0) 1.1 4 (4.2) 2.1
Log-rank P-value 0.151 0.445 0.301 0.563 0.106
Significant CAD 435 23 (5.3) 7 (1.6) 14 (3.2) 21 (4.8) 2.2 37 (8.5) 3.8
Right dominant 400 15 (3.8) 2 (0.5) 11 (2.8) 13 (3.3) 2.0 26 (6.5) 3.2
Left dominant 35 8 (23) 5 (14) 3 (8.6) 8 (23) 7.9 11 (31) 9.9
Log-rank P-value ,0.001 0.010 0.059 ,0.001 ,0.001
CAD, coronary artery disease; CTA, computed tomography coronary angiography; MI, myocardial infarction.
Annual event rates were calculated by dividing the Kaplan–Meier event rates by mean number of years of follow-up. Patient with a balanced coronary artery systemwere excluded
from the analysis.
aOne patient with a balanced coronary artery system without significant CAD on CTA died because of non-cardiac death; accordingly in the total population of 1425 patients,
39 patients died.
Figure 1 Kaplan–Meier curve for non-fatal myocardial infarction and all-cause mortality in patients with a right dominant, left dominant, and
balanced coronary artery system. In the total study population statistically significant difference in event-free survival according to coronary
vessel dominance was observed, showing a worse outcome in patients with a left dominant coronary artery system (log-rank P, 0.001).
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P ¼ 0.016) for two- and three-vessel disease, respectively. No
interaction was observed for the effect of a right dominant vs.
left dominant coronary artery system and the absence vs. the pres-
ence of significant CAD on CTA for non-fatal MI and all-cause
mortality (P-value for interaction ¼ 0.227). Furthermore, a signifi-
cant increase in global Chi-square values confirmed that CAD on
CTA had incremental value over clinical risk factors (53.05 vs.
36.32, P ¼ 0.025) and that coronary vessel dominance had incre-
mental value over CAD and clinical risk factors (65.53 vs. 52.05,
P ¼ 0.006) (Figure 3). Additionally, in reduced Cox regression
models a left dominant coronary artery system remained a signifi-
cant predictor for non-fatal MI and all-cause mortality with com-
parable risk estimates, when correcting for overall plaque burden
(model 1), proximally located CAD (model 2), and the number
of vessels with significant stenosis on CTA (Table 5). Subsequently,
overall plaque burden, proximally located CAD and the number of
vessels affected were identified as predictors of non-fatal MI and
all-cause mortality with the highest HR of 1.68 (95% CI: 1.32–
2.14, P, 0.001) for the number of vessels affected.
In addition, sub-analysis assessing the independent prognostic
value of coronary vessel dominance for the occurrence of non-
fatal MI and cardiac death (extensive analysis is not shown)
revealed that a left dominant coronary artery system remained a
significant predictor of cardiac events (HR between 5.13 and
5.66 when corrected for significant CAD, overall plaque burden,
or proximally located CAD, for all analyses P, 0.001).
Prognostic value of significant stenosis
location
A stenosis in the left coronary system was observed in 222 patients
and was associated with an increased risk of non-fatal MI and all-
cause mortality, with a HR of 2.79 (95% CI: 1.46–5.31, P ¼
0.002) (Table 6). In case of a stenosis in both (right and left)
Figure 2 Kaplan–Meier curve for non-fatal myocardial infarction and all-cause mortality in patients with a right dominant and left dominant
coronary artery system, stratified for the presence of significant coronary artery disease on computed tomography coronary angiography. (A)
Patients without significant coronary artery disease on computed tomography coronary angiography. (B) Patients with significant coronary
artery disease on computed tomography coronary angiography. Patients with balanced coronary artery system were excluded from the analysis,
because of the low number of patients in this group. Patients without significant coronary artery disease on computed tomography coronary
angiography (A) had good event-free survival, showing no statistically significant difference in event-free survival between patients with a left
dominant and a right dominant coronary artery system in this patient category (log-rank P ¼ 0.106). In the subgroup of patients with significant
coronary artery disease on computed tomography coronary angiography (B), patients with a left dominant coronary artery system had a stat-
istically significant worse outcome compared with patients with a right dominant coronary artery system (log-rank P, 0.001). CAD, coronary
artery disease; CTA, computed tomography coronary angiography.
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coronary systems, as was present in 150 patients, a HR of 3.05
(95% CI: 1.47–6.31, P ¼ 0.003) was observed. A significant sten-
osis in the right coronary system, as observed in 63 patients, was
not significantly associated with the composite endpoint. Further-
more, in patients with a right dominant coronary artery system, a
stenosis in the left coronary system and a stenosis in both (right
and left) coronary systems were associated with an increased
risk of events with a HR of 2.41 (95% CI: 1.14–5.12, P ¼ 0.022)
and a HR of 3.12 (95% CI: 1.40–6.98, P ¼ 0.006), respectively. Sub-
sequently, in patients with a left dominant coronary artery system,
a stenosis in the left coronary system was associated with an
increased risk of non-fatal MI and all-cause death, with a HR of
5.00 (95% CI: 1.35–18.43, P ¼ 0.016). The difference in the risk es-
timate of a stenosis in the left coronary system in patients with a
right dominant and patients with a left dominant coronary artery
system was statistically non-significant (HR of 2.4 and HR of 5.0,
respectively; P-value for interaction ¼ 0.351).
Discussion
This study demonstrated that coronary vessel dominance assessed
by CTA has incremental prognostic value and extends the predict-
ive value of CTA. The main finding of the study were that the pres-
ence of a left dominant coronary artery system is associated with
an increased risk of non-fatal MI and all-cause mortality when
compared with a right dominant coronary artery system. More-
over, the presence of significant CAD on CTA in patients with a
left dominant coronary artery system was associated with a
worse outcome than significant CAD on CTA in patients with a
right dominant coronary artery system. These findings suggest
that the assessment of coronary vessel dominance using CTA
may further enhance the risk stratification beyond the assessment
of the degree of stenosis in patients referred for CTA.
The prognostic value of significant CAD using CTA is well estab-
lished, and an increased risk of cardiovascular events in patients
with significant CAD on CTA has been previously demon-
strated.4–6,18,19 These findings are confirmed in the present
study, showing a higher risk of events in patients with significant
CAD on CTA, regardless of coronary vessel dominance. While
coronary vessel dominance is routinely assessed using CTA,
limited information is available about the prognostic value of cor-
onary vessel dominance in patients referred for CTA. A previous
study by Goldberg et al. showed that, in a large cohort of patients
(n ¼ 27 289) who underwent cardiac catheterization due to acute
coronary syndrome, the presence of a left dominant coronary
artery system was a predictor of death at a mean follow-up dur-
ation of 3.5 years (HR: 1.18, 95% CI: 1.05–1.34).20 The prognostic
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Table 4 Multivariate Cox regression analysis for the
composite endpoint of non-fatal myocardial infarction
and all-cause mortality including clinical risk factors,
CTA results and coronary vessel dominance
HR (95% CI) P-value
Clinical risk factors
Age 1.06 (1.03–1.08) ,0.001
Gender (male) 1.33 (0.76–2.33) 0.320
Known CAD 1.25 (0.65–2.40) 0.506
Smoking 3.03 (1.79–5.12) ,0.001
Diabetes 1.53 (0.86–2.72) 0.146
CTA results
Normal CTA or minor wall
irregularities (,30%)
1.0 (reference)
Non-significant CAD (30–50%) 1.44 (0.53–3.88) 0.473
One-vessel disease (.50%) 2.79 (1.03–7.60) 0.045
Two-vessel disease (.50%) 3.59 (1.24–10.40) 0.019
Three-vessel disease (.50%) 4.14 (1.31–13.06) 0.016
Coronary vessel dominance
Right dominant coronary artery
system
1.0 (reference)
Left dominant coronary artery
system
3.20 (1.67–6.13) ,0.001
Balanced coronary artery system 0.82 (0.11–6.05) 0.842
CAD, coronary artery disease; CI, confidence interval; CTA, computed
tomography coronary angiography; HR, hazard ratio.
Figure 3 Bar graph illustrating the incremental prognostic value
(depicted by x2 values on the y-axis) clinical risk factors, com-
puted tomography coronary angiography results, and coronary
vessel dominance. The presence of significant coronary artery
disease on computed tomography coronary angiography had a
significant incremental prognostic value over the clinical risk
factors of age, gender, known coronary artery disease, smoking,
and diabetes (P ¼ 0.025). A further incremental prognostic
value over clinical risk factors and significant coronary artery
disease on computed tomography coronary angiography were
observed with the addition of coronary vessel dominance
(P ¼ 0.006). The computed tomography coronary angiography
results included in the model consisted of the five categories:
normal coronaries or minimal wall irregularities (,30%), non-
obstructive coronary artery disease (30–50%) and one-, two-,
and three-vessel disease (.50%). CAD, coronary artery
disease; CTA, computed tomography coronary angiography.
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value of coronary vessel dominance was most pronounced in
patients with acute ST-segment elevation MI. It is remarkable
that the hazard of the presence of a left dominant coronary
artery system was less pronounced in the study by Goldberg
et al. compared with the hazard observed in the current study
(HR: 3.20, 95% CI: 1.67–6.13). However, the study population
may have differed substantially between our investigation and the
one by Goldberg et al. The event rate in the study population of
Goldberg et al. was higher in all coronary vessel dominance
groups since their population consisted of high-risk patients,
when compared with low- to intermediate-risk patients in our
population. Because of the overall worse prognosis in all patients,
the difference between groups could be less pronounced. Further-
more, the outcome measure of Goldberg et al. was all-cause mor-
tality, whereas in the present study also non-fatal MI was included
as a primary endpoint in addition to all-cause mortality. These dif-
ferences in study population and outcome are expected to account
for the difference in findings between studies. Importantly, the
prognostic value of coronary vessel dominance in patients with
and without significant CAD was evaluated in the present study.
Patients without significant CAD on CTA were shown to have a
good prognosis irrespective of coronary vessel dominance.
These findings confirm the excellent prognostic value of a CTA
examination without significant CAD.21 In addition, this study
showed that in patients with significant CAD on CTA the presence
of a left dominant coronary artery system significantly increased
the risk of non-fatal MI and all-cause mortality as well as for
adverse cardiac events including cardiac death as confirmed by
sub-analysis.
The extent of atherosclerosis in relation
to coronary vessel dominance
Although limited information is currently available regarding the
prognostic value of coronary vessel dominance, the relationship
between coronary vessel dominance and anatomical variance of
the coronary arteries was investigated in several different studies.
A study by Dodge et al., evaluating 83 invasive coronary angio-
grams, demonstrated a smaller RCA diameter and a larger LCX
diameter in patients with a left dominant coronary artery
system.22 In addition, Ilia et al. found that a long LAD (defined as
an LAD wrapped around the apex of the heart) was present in
87% of patients with a left dominant coronary artery system com-
pared with 47% of patients with a right dominant coronary artery
system.23
Futhermore, the relationship between coronary vessel domin-
ance and the extent of CAD remains uncertain as different
studies showed opposing results. The aforementioned study by
Goldberg et al. showed more extensive CAD in patients with a
right dominant coronary artery system as compared with patients
with a left dominant coronary artery system.20 Similar findings
were shown in the study by Vasheghani-Farahani et al., identifying
a higher prevalance of three-vessel disease in patients with a
right dominant coronary artery system.24 However, Balci et al.
did not find a significant difference in the extent of significant
CAD between patients with a right and left dominant coronary
artery system.25 Although the current study did not reveal signifi-
cant differences in the distribution of significant CAD on CTA,
normal CTA results or wall irregularities causing ,30% luminal
narrowing were observed less frequently in patients with a right
dominant coronary artery system compared with patients with
left dominant and balanced coronary artery systems. Still, for the
determination of the relationship between the extent of significant-
ly CAD and coronary vessel dominance, more extensive research
is required in larger patient populations.
Underlying mechanisms
At present, little is known about the prognostic value of significant
stenosis location in relation to coronary vessel dominance. This
study demonstrated that a stenosis in the left coronary system,
meaning the LAD and/or LCX, was associated with an increased
risk of events, while a stenosis in the RCA did not statistically sig-
nificant predict events. The hazard of a stenosis in the left coronary
system was comparable between patients with a right dominant
and left dominant coronary artery system. Still, coronary vessel
dominance has influence on the relative contribution of the differ-
ent coronary arteries to the total left ventricular blood flow.23,26
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Table 5 Reduced Cox regression models of age and
gender, CTA results and coronary vessel dominance for
the composite endpoint of non-fatal myocardial
infarction and all-cause mortality
HR (95% CI) P-value
Model 1: overall Plaque burden on CTA
Age 1.05 (1.02–1.08) ,0.001
Gender 1.28 (0.71–2.30) 0.406
Number of segments diseased
(.30%)
1.14 (1.06–1.23) ,0.001
Left dominant coronary artery
system
3.97 (2.11–7.50) ,0.001
Model 2: proximally located CAD on CTA
Age 1.04 (1.01–1.07) 0.004
Gender 1.32 (0.74–2.36) 0.341
Proximal diseased segments
(.30%)
1.48 (1.20–1.83) ,0.001
Left dominant coronary artery
system
3.77 (2.00–7.10) ,0.001
Model 3: extent of significant CAD on CTA
Age 1.04 (1.02–1.07) 0.002
Gender 1.45 (0.82–2.56) 0.199
Number of vessels with significant
stenosis (.50%)
1.68 (1.32–2.14) ,0.001
Left dominant coronary artery
system
3.72 (1.98–6.99) ,0.001
CAD, coronary artery disease; CI, confidence interval; CTA, computed
tomography coronary angiography; HR, hazard ratio.
Overall plaque burden was assessed by the number of diseased segments including
all plaques causing .30% luminal narrowing (model 1). Proximally located CAD
was defined as non-significant and significant stenosis in all proximally located
segments (model 2). The number of vessels with significant stenosis (.50%)
included one-, two-, and three-vessel disease and was entered into the models as a
continuous variable (model 3).
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The anatomic importance of a significant stenosis in patients with
left dominant coronary artery system might be different from that
in patients with a right dominant or balanced coronary artery
system. In risk scores the weight factors for a significant stenosis
in the segments of the coronary tree differ for patients with a
right and a left dominant coronary artery system, with higher
scores for the segments of the LAD and LCX in patients with a
left dominant coronary artery system.26 In patients with a left dom-
inant coronary artery system, the left ventricle receives almost the
entire blood supply from the LAD and the LCX, possibly resulting
in more extensive MI, in case of a significant stenosis in these
vessels. Moreover, the possibility to form collaterals might be
less in patients with a left dominant coronary artery system.
Since the PDA originating from the RCA is lacking, no collaterals
can be formed from the right coronary system, when the left cor-
onary system is suffering from a severe stenosis. At present,
however, no studies are available investigating the relationship
between coronary vessel dominance and severity of MI or forma-
tion of coronary collateral circulation. Therefore, further research
is needed to identify factors contributing to the inferior prognosis
of patients with a left dominant coronary artery system.
Clinical implication
In patients referred for CTA, a left dominant coronary artery
system was identified as a significant risk factor for MI and death.
Particularly in the subgroup of patients with significant CAD on
CTA, those patients with a left dominant coronary artery system
had a strongly increased risk of events compared with patients
with a right dominant coronary artery system. Therefore, the po-
tential indication for intensive treatment could be more prominent
in patients with a left dominant coronary artery system. Further-
more, in case of uncertainty about the need for referral for revas-
cularization, subsequent testing for ischaemia might reveal
important information that may assist in clinical decision-making.
In current clinical practice, no clear distinction is made in the treat-
ment strategies between patients with a right dominant and a left
dominant coronary artery system. When other studies will confirm
the results of our study, the knowledge of the prognostic impact of
coronary vessel dominance might affect the choice of treatment.
Accordingly, the evaluation of coronary vessel dominance could
assist in clinical decision making and prognostication in patients re-
ferred for CTA.
Limitations
The current study has several limitations. First, the study was con-
ducted in a relatively small patient population, which results in a
comparatively small group of patients with a left dominant coron-
ary artery system, and an even smaller group for patients with a
balanced coronary artery system. Of note, the prevalence of
right dominant, left dominant, and balanced coronary artery
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Table 6 Cox regression analysis of significant stenosis location for non-fatal myocardial infarction and all-cause
mortality in patients with a right dominant and patients with a left dominant coronary artery system
Variable n Univariate Multivariate
HR (95% CI) P-value HR (95% CI) P-value
All patients 1387
No significant CAD (,50%) 952 1.0 (reference) 1.0 (reference)
Significant stenosis in the right coronary systema 63 3.11 (1.07–9.08) 0.037 2.25 (0.76–6.65) 0.142
Significant stenosis in the left coronary systemb 222 3.54 (1.90–6.59) ,0.001 2.79 (1.46–5.31) 0.002
Significant stenosis in both coronary systemsc 150 4.20 (2.10–8.39) ,0.001 3.05 (1.47–6.31) 0.003
Patients with right dominant coronary artery system 1256
No significant CAD (,50%) 856 1.0 (reference) 1.0 (reference)
Significant stenosis in the right coronary system 61 1.94 (0.45–6.65) 0.376 1.48 (0.34–5.12) 0.602
Significant stenosis in the left coronary system 196 3.20 (1.54–6.65) 0.002 2.41 (1.14–5.12) 0.022
Significant stenosis in both coronary systems 143 4.44 (2.06–9.57) ,0.001 3.12 (1.40–6.98) 0.006
Patients with left dominant coronary artery system 131
No significant CAD (,50%) 96 1.0 (reference) 1.0 (reference)
Significant stenosis in the right coronary systemd 2 — —
Significant stenosis in the left coronary system 26 5.30 (1.49–18.82) 0.010 5.00 (1.35–18.43) 0.016
Significant stenosis in both coronary systems 7 5.68 (1.03–31.42) 0.046 4.81 (0.85–27.16) 0.075
CAD, coronary artery disease; CI, confidence interval; HR, hazard ratio; LAD, left anterior descending artery; LCX, left circumflex artery; LM, left main artery; RCA, right coronary
artery.
Patients with a balanced coronary artery system were excluded from the analysis. Multivariate analysis correcting for age and gender was performed. Patients without significant
CAD on CTA were considered the reference group.
aStenosis in the right coronary system ¼ at least one significant stenosis in the RCA.
bStenosis in the left coronary system ¼ at least one significant stenosis in the LM, LAD, and/or LCX.
cStenosis in both coronary systems ¼ at least one significant stenosis in the RCA and the LM, LAD, and/or LCX.
dHazard ratios could not be calculated for patients with a left dominant coronary artery system and a stenosis in the right coronary system, due to the very small number of
patients within this group.
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systems in the present study population is comparable with that
described in the previous literature.9 Because of the small
patient groups among patients with significant CAD on CTA, stat-
istically significant difference between the risk estimates for having
a significant stenosis in the left coronary systems in patients with a
right and a left dominant coronary artery system was not observed,
presumably due to insufficient power. Larger studies are needed to
elucidate the relationship between significant stenosis location and
coronary vessel dominance. Secondly, plaque composition, which
may have impact on outcome as well, was not evaluated. In add-
ition, to what extent severely calcified plaques may potentially
have influenced the assessment of stenosis severity remains
unknown. Thirdly, the multivariate Cox regression model in the
current analysis was at the edge of overfitting, due to a relatively
low number of clinical events in the present study. However, the
CIs observed in the Cox regression analysis were considered reli-
able and reduced Cox regression models could confirm the prog-
nostic value of coronary vessel dominance. Fourthly, 5.5% of
patients were lost to follow-up. However, no difference in the dis-
tribution of coronary vessel dominance was observed in patients
without follow-up. Fifthly, because of the relatively low event rate
in the current study, larger studies are needed to evaluate the
effect of coronary vessel dominance on cardiac adverse events
like the composite of non-fatal MI and cardiac death. Instead, the
composite of non-fatal MI and all-cause mortality was the primary
endpoint in the current study. Subsequently, future studies in
larger patient cohorts are warranted to confirm these findings.
Conclusions
The presence of a left dominant coronary artery system is asso-
ciated with an increased risk of non-fatal MI and all-cause mortality.
Furthermore, coronary vessel dominance has significant incremen-
tal prognostic value over clinical risk factors and significant CAD
on CTA. In addition, the presence of significant CAD on CTA in
patients with a left dominant coronary artery system is associated
with a worse outcome than the presence of significant CAD in
patients with a right dominant coronary artery system. Therefore,
the assessment of coronary vessel dominance may further enhance
risk stratification beyond the assessment of severity and extent of
CAD on CTA. However, the underlying mechanism is unknown
and its application therefore remains speculative.
Funding
C.E.V. is financially supported by a research grant from the Interuniver-
sity Cardiology Institute of the Netherlands (ICIN, Utrecht, The
Netherlands). F.R.G. is partly supported by the Dutch Technology
Foundation STW (Utrecht, the Netherlands), applied science division
of NWO and the Technology Program of the Ministry of Economic
Affairs, grant no. 10084. P.A.K. is supported by a grant from the Swiss
National Science Foundation (SNSF). J.J.B. receives grants from Biotro-
nik, Lantheus medical imaging, Boston Scientific, Edwards Lifesciences,
GE Healthcare, Medtronic and St. Jude Medical. M.J.S. receives grants
from Biotronik, Boston Scientific & Medtronic.
Conflict of interest: none declared.
References
1. de Graaf FR, Schuijf JD, van Velzen JE, Kroft LJ, de RA, Reiber JH, Boersma E,
Schalij MJ, Spano F, Jukema JW, van der Wall EE, Bax JJ. Diagnostic accuracy of
320-row multidetector computed tomography coronary angiography in the non-
invasive evaluation of significant coronary artery disease. Eur Heart J 2010;31:
1908–1915.
2. Meijboom WB, Meijs MF, Schuijf JD, Cramer MJ, Mollet NR, van Mieghem CA,
Nieman K, van Werkhoven JM, Pundziute G, Weustink AC, de Vos AM,
Pugliese F, Rensing B, Jukema JW, Bax JJ, Prokop M, Doevendans PA,
Hunink MG, Krestin GP, de Feyter PJ. Diagnostic accuracy of 64-slice computed
tomography coronary angiography: a prospective, multicenter, multivendor study.
J Am Coll Cardiol 2008;52:2135–2144.
3. Miller JM, Rochitte CE, Dewey M, Arbab-Zadeh A, Niinuma H, Gottlieb I, Paul N,
Clouse ME, Shapiro EP, Hoe J, Lardo AC, Bush DE, de RA, Cox C, Brinker J,
Lima JA. Diagnostic performance of coronary angiography by 64-row CT.
N Engl J Med 2008;359:2324–2336.
4. Min JK, Shaw LJ, Devereux RB, Okin PM, Weinsaft JW, Russo DJ, Lippolis NJ,
Berman DS, Callister TQ. Prognostic value of multidetector coronary computed
tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol
2007;50:1161–1170.
5. van Werkhoven JM, Schuijf JD, Gaemperli O, Jukema JW, Kroft LJ, Boersma E,
Pazhenkottil A, Valenta I, Pundziute G, de RA, van der Wall EE, Kaufmann PA,
Bax JJ. Incremental prognostic value of multi-slice computed tomography coron-
ary angiography over coronary artery calcium scoring in patients with suspected
coronary artery disease. Eur Heart J 2009;30:2622–2629.
6. Chow BJ, Small G, Yam Y, Chen L, Achenbach S, Al-Mallah M, Berman DS,
Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Cheng V, Chinnaiyan KM,
Delago A, Dunning A, Hadamitzky M, Hausleiter J, Kaufmann P, Lin F, Maffei E,
Raff GL, Shaw LJ, Villines TC, Min JK. Incremental prognostic value of cardiac com-
puted tomography in coronary artery disease using CONFIRM: COroNary com-
puted tomography angiography evaluation for clinical outcomes: an InteRnational
Multicenter registry. Circ Cardiovasc Imaging 2011;4:463–472.
7. Ostrom MP, Gopal A, Ahmadi N, Nasir K, Yang E, Kakadiaris I, Flores F, Mao SS,
Budoff MJ. Mortality incidence and the severity of coronary atherosclerosis
assessed by computed tomography angiography. J Am Coll Cardiol 2008;52:
1335–1343.
8. Angelini P, Velasco JA, Flamm S. Coronary anomalies: incidence, pathophysiology,
and clinical relevance. Circulation 2002;105:2449–2454.
9. Cademartiri F, La GL, Malago R, Alberghina F, Meijboom WB, Pugliese F, Maffei E,
Palumbo AA, Aldrovandi A, Fusaro M, Brambilla V, Coruzzi P, Midiri M,
Mollet NR, Krestin GP. Prevalence of anatomical variants and coronary anomalies
in 543 consecutive patients studied with 64-slice CT coronary angiography.
Eur Radiol 2008;18:781–791.
10. Gorlin R. Coronary anatomy. Major Probl Intern Med 1976;11:40–58.
11. Gaemperli O, Schepis T, Kalff V, Namdar M, Valenta I, Stefani L, Desbiolles L,
Leschka S, Husmann L, Alkadhi H, Kaufmann PA. Validation of a new cardiac
image fusion software for three-dimensional integration of myocardial perfusion
SPECT and stand-alone 64-slice CT angiography. Eur J Nucl Med Mol Imaging
2007;34:1097–1106.
12. Schuijf JD, Wijns W, Jukema JW, Atsma DE, de RA, Lamb HJ, Stokkel MP,
Dibbets-Schneider P, Decramer I, De BP, van der Wall EE, Vanhoenacker PK,
Bax JJ. Relationship between noninvasive coronary angiography with multi-slice
computed tomography and myocardial perfusion imaging. J Am Coll Cardiol
2006;48:2508–2514.
13. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, McGoon DC,
Murphy ML, Roe BB. A reporting system on patients evaluated for coronary
artery disease. Report of the Ad Hoc Committee for Grading of Coronary
Artery Disease, Council on Cardiovascular Surgery, American Heart Association.
Circulation 1975;51:5–40.
14. de Graaf FR, Schuijf JD, van Velzen JE, Boogers MJ, Kroft LJ, de RA, Reiber JH,
Sieders A, Spano F, Jukema JW, Schalij MJ, van der Wall EE, Bax JJ.
Diagnostic accuracy of 320-row multidetector computed tomography coronary
angiography to noninvasively assess in-stent restenosis. Invest Radiol 2010;45:
331–340.
15. Schuijf JD, Pundziute G, Jukema JW, Lamb HJ, Tuinenburg JC, van der Hoeven BL,
de RA, Reiber JH, van der Wall EE, Schalij MJ, Bax JJ. Evaluation of patients with
previous coronary stent implantation with 64-section CT. Radiology 2007;245:
416–423.
16. Chow BJ, Wells GA, Chen L, Yam Y, Galiwango P, Abraham A, Sheth T, Dennie C,
Beanlands RS, Ruddy TD. Prognostic value of 64-slice cardiac computed tomog-
raphy severity of coronary artery disease, coronary atherosclerosis, and left ven-
tricular ejection fraction. J Am Coll Cardiol 2010;55:1017–1028.
17. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction.
Eur Heart J 2007;28:2525–2538.
C.E. Veltman et al.1376
18. Buechel RR, Pazhenkottil AP, Herzog BA, Brueckner M, Nkoulou R, Ghadri JR,
Kuest SM, Wyss CA, Husmann L, Kaufmann PA. Prognostic performance of
low-dose coronary CT angiography with prospective ECG triggering. Heart
2011;97:1385–1390.
19. Gaemperli O, Valenta I, Schepis T, Husmann L, Scheffel H, Desbiolles L,
Leschka S, Alkadhi H, Kaufmann PA. Coronary 64-slice CT angiography predicts
outcome in patients with known or suspected coronary artery disease. Eur Radiol
2008;18:1162–1173.
20. Goldberg A, Southern DA, Galbraith PD, Traboulsi M, Knudtson ML, Ghali WA.
Coronary dominance and prognosis of patients with acute coronary syndrome.
Am Heart J 2007;154:1116–1122.
21. Abdulla J, Asferg C, Kofoed KF. Prognostic value of absence or presence of cor-
onary artery disease determined by 64-slice computed tomography coronary
angiography: a systematic review and meta-analysis. Int J Cardiovasc Imaging
2011;27:413–420.
22. Dodge JT Jr, Brown BG, Bolson EL, Dodge HT. Lumen diameter of normal human
coronary arteries. Influence of age, sex, anatomic variation, and left ventricular
hypertrophy or dilation. Circulation 1992;86:232–246.
23. Ilia R, Rosenshtein G, Weinstein J, Cafri C, Abu-Ful A, Gueron M. Left anterior
descending artery length in left and right coronary artery dominance. Coron
Artery Dis 2001;12:77–78.
24. Vasheghani-Farahani A, Kassaian SE, Yaminisharif A, Davoodi G, Salarifar M,
Amirzadegan A, Darabian S, Fotouhi A, Sadigh G, Razavi SA, Hakki E. The asso-
ciation between coronary arterial dominancy and extent of coronary artery
disease in angiography and paraclinical studies. Clin Anat 2008;21:519–523.
25. Balci B, Yilmaz O. Atherosclerotic involvement in patients with left or right dom-
inant coronary circulation. Kardiol Pol 2004;60:564–566.
26. Leaman DM, Brower RW, Meester GT, Serruys P, van den Brand M. Coronary
artery atherosclerosis: severity of the disease, severity of angina pectoris and
compromised left ventricular function. Circulation 1981;63:285–299.
Prognostic value of coronary vessel dominance 1377
